Acumen Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1996-01-01
- Employees
- 52
- Market Cap
- $168.8M
- Website
- http://www.acumenpharm.com
- Introduction
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants
Phase 1
Completed
- Conditions
- Alzheimer Disease
- Interventions
- Drug: sabirnetug (ACU193)Combination Product: Sabirnetug + rHuPH20
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Acumen Pharmaceuticals
- Target Recruit Count
- 28
- Registration Number
- NCT06511570
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants with Early Alzheimer's Disease (ALTITUDE-AD)
Phase 2
Active, not recruiting
- Conditions
- Alzheimer Disease
- Interventions
- Drug: PlaceboDrug: sabirnetug
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Acumen Pharmaceuticals
- Target Recruit Count
- 540
- Registration Number
- NCT06335173
- Locations
- 🇺🇸
Irvine Medical Research, Irvine, California, United States
🇺🇸Healthy Brain Research, Long Beach, California, United States
🇺🇸Syrentis Clinical Research, Santa Ana, California, United States
A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD
Phase 1
Completed
- Conditions
- Alzheimer Disease
- Interventions
- Drug: PlaceboDrug: ACU193
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Acumen Pharmaceuticals
- Target Recruit Count
- 65
- Registration Number
- NCT04931459
- Locations
- 🇺🇸
iResearch Atlanta, Decatur, Georgia, United States
🇺🇸Combined Research Orlando Phase I-IV, Orlando, Florida, United States
🇺🇸Velocity Clinical Research, Hallandale Beach, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath